Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy, according to new information released today from a large scale controlled clinical study that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.

19 Apr 2017

Microscopic probes simplify process of measuring electrical signals in small animals

Microscopic probes developed at Rice University have simplified the process of measuring electrical activity in individual cells of small living animals. The technique allows a single animal like a worm to be tested again and again and could revolutionize data-gathering for disease characterization and drug interactions.

17 Apr 2017

Cell cultures in petri dishes open new doors to brain research

The most complex organ in humans is the brain. Due to its complexity and, of course, for ethical reasons, it is extremely difficult to do scientific experiments on it - ones that could help us to understand neurodegenerative diseases like Parkinson's, for example.

13 Apr 2017

Opportunities and risks of direct-to-consumer genetic health risk tests

Accurate genetic testing stands to transform modern medicine by offering effective, personalized treatment.

13 Apr 2017

Obesity and being underweight linked to increased risk for migraine

Both obesity and being underweight are associated with an increased risk for migraine, according to a meta-analysis published in the April 12, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Apr 2017

'Human knockouts': Genetics in families reveals basic biology and possible therapeutics for disorders

More than 1,800 individuals carrying loss-of-function mutations in both copies of their genes, so-called "human knockouts," are described in the first major study to be published in Nature this week by an international collaboration led by the Perelman School of Medicine at the University of Pennsylvania and colleagues.

12 Apr 2017

Study shows um-PEA as safe and efficacious adjuvant treatment for advanced PD patients

Parkinson disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.

12 Apr 2017

Researchers design first light-activated drug for treatment of pain

A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug -the JF-NP-26, for the treatment of pain, according to a research with animal models published in the journal eLife.

11 Apr 2017

New study finds link between neural tube defects in infants and neurodegenerative diseases

A new study has found a link between neurological birth defects in infants commonly found in pregnant women with diabetes and several neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases.

10 Apr 2017

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

7 Apr 2017

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

A surgical technique that sends electrical impulses to a specific area of the brain reduces the "tics," or involuntary movements and vocal outbursts, experienced by young adults with severe cases of Tourette syndrome, according to a new study led by investigators from NYU Langone Medical Center.

7 Apr 2017

Biomedical engineers develop new method for delivering drugs to specific neurons

Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.

6 Apr 2017

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions.

6 Apr 2017

Regular exercise, not body fat, may help predict person's recovery from stroke

A new study suggests it's the amount of regular exercise people get, not the amount of body fat they have, that may predict just how well they recover from a stroke.

6 Apr 2017

Digitising health records could have positive impact on diagnosis and treatment of illnesses

Digitising health records to include key patient and treatment information could help identify patterns of illness, effectiveness of treatments and how these patients' gender and ethnicity influence this.

3 Apr 2017

Common neurological diseases pose serious annual financial burden for the U.S.

The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.

30 Mar 2017

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The hepatitis virus affects the liver.

29 Mar 2017

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Microscopic probes simplify process of measuring electrical signals in small animals

Cell cultures in petri dishes open new doors to brain research

Opportunities and risks of direct-to-consumer genetic health risk tests

Obesity and being underweight linked to increased risk for migraine

'Human knockouts': Genetics in families reveals basic biology and possible therapeutics for disorders

Study shows um-PEA as safe and efficacious adjuvant treatment for advanced PD patients

Researchers design first light-activated drug for treatment of pain

New study finds link between neural tube defects in infants and neurodegenerative diseases

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

Biomedical engineers develop new method for delivering drugs to specific neurons

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

Regular exercise, not body fat, may help predict person's recovery from stroke

Digitising health records could have positive impact on diagnosis and treatment of illnesses

Common neurological diseases pose serious annual financial burden for the U.S.

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

Cerebellar stimulation improves schizophrenia-like thinking problems in rats

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

Research findings could help understand how Parkinson's develops on molecular level

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in